Quick Answer
ZEVRA THERAPEUTICS, INC. reported Stockholders Equity of $154.66 million for fiscal year 2025.
ZEVRA THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $154.66M | +289.9% |
| 2024 | $39.67M | -35.9% |
| 2023 | $61.86M | +0.6% |
| 2023 | $61.52M | -18.1% |
| 2022 | $75.12M | -26.1% |
| 2021 | $101.66M | +253.1% |
| 2020 | -$66.41M | +10.8% |
| 2019 | -$74.46M | -11.9% |
| 2018 | -$66.57M | -15.7% |
| 2017 | -$57.52M | -207.6% |
| 2016 | -$18.70M | -84.7% |
| 2015 | -$10.12M | +79.1% |
| 2014 | -$48.51M | -99.9% |
| 2013 | -$24.27M | -26.6% |
| 2012 | -$19.18M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $133.16M | +90.9% | +13.6% |
| June 30, 2025 | $117.23M | +261.0% | +185.8% |
| March 31, 2025 | $41.02M | -16.0% | +3.4% |
| December 31, 2024 | $39.67M | -35.9% | -43.1% |
| September 30, 2024 | $69.77M | +13.4% | +114.8% |
| June 30, 2024 | $32.48M | -44.8% | -33.5% |
| March 31, 2024 | $48.82M | -17.6% | -21.1% |
| December 31, 2023 | $61.86M | -27.9% | +0.6% |
- ZEVRA THERAPEUTICS, INC. showed an increase of +289.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, ZEVRA THERAPEUTICS, INC.’s stockholders equity has grown by 906.6% (from -$19.18 million to $154.66 million).
- The most recent figure is from ZEVRA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: